{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02842",
      "entity_text" : "sCD40L",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0800" ],
      "Cellular_component" : [ "go:GO:0016020" ],
      "CellType" : [ "cl:CL:0000233" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Increased levels of sCD40L or sGPVI XREF_BIBR XREF_BIBR in conjunction with a reduction of surface GPIba or GPVI, XREF_BIBR platelet derived chemokines XREF_BIBR and serotonin XREF_BIBR in platelet-free plasma, or of circulating platelet derived microparticles XREF_BIBR XREF_BIBR XREF_BIBR and platelet-monocyte aggregates XREF_BIBR in whole blood have been reported in these patients.",
  "reading_complete" : "2020-08-03T14:30:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:27:37Z",
  "trigger" : "levels",
  "evidence" : [ "levels of sCD40L" ],
  "pmc_id" : "6598084",
  "score" : 0
}